SICKLE CELL DISEASE THERAPY- ADDENDUM NIH GUIDE, Volume 25, Number 1, January 26, 1996 RFA: HL-96-001 P.T. 34 Keywords: Blood Diseases Biology, Cellular Biology, Molecular Chemotherapeutic Agents National Heart, Lung, and Blood Institute Letter of Intent Receipt Date: February 20, 1996 (Revised) Application Receipt Date: March 19, 1996 (Revised) The National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) announces the following modification to RFA HL-96-001, which was published in the NIH Guide, Vol. 24, No. 40, November 24, 1995. Schedule The letter of intent receipt date is extended from December 22, 1995 to February 20, 1996. The application receipt date is extended from January 23, 1996 to March 19, 1996. The anticipated award date is September 1996. Direct inquiries regarding programmatic issues to: Dr. Junius G. Adams, III Division of Blood Diseases and Resources National Heart, Lung, and Blood Institute 6701 Rockledge Drive Bethesda, MD 20892-7950 Telephone: (301) 435-0055 FAX: (301) 480-0868 Email: ja33m@nih.gov Inquiries regarding fiscal matters or collaborative arrangements involving subcontracts with other institutions may be directed to: Ms. Jane R. Davis Blood Division Grants Management Section National Heart, Lung, and Blood Institute 6701 Rockledge Drive Bethesda, MD 20892-7926 Telephone: (301) 435-0166 FAX: (301) 480-3310 .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |